Nonpartisan civic infrastructure
AllCiv·Legis1
·

S. 5316

BillFederalSenateIn Committee
To protect access to kratom.
About This Bill
Committee
Latest Action · December 20, 2022
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Congress
117th (2021–2023)
Introduced
December 20, 2022
Cosponsors (1)
1D 0R
View PDF ↗

Summary

Highlight any text to annotate
Federal Clarity for Kratom Consumers Act This bill requires the Food and Drug Administration (FDA) to hold a hearing and establish a task force on the health and safety of products with kratom (an herbal substance that produces opioid- and stimulant-like effects). It also prohibits the FDA from regulating kratom products in a manner that is more restrictive as compared to regulations for food, dietary supplements, or dietary ingredients.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.